Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583595 · ClinicalTrials.gov registry record
Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 70
- Enrollment target
NCT01583595: Completed study, sponsored by Mayo Clinic.
NCT01583595 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01583595 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait speed and physical activity level-PAL- (total energy expenditure/resting metabolic rate). Quality of life, self efficacy for activity questionnaires, physical activity level measurement, 4-meter gait speed and 6-minute walk distance will be measured.
Primary Outcome
Correlation , regression models and mediation analysis (self efficacy and physical activity) will be performed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-07 |
What the finished NCT01583595 record still lists
NCT01583595 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01583595 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01583595 about?
NCT01583595 is a clinical study titled "Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease". Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait spee...
What is the current status of trial NCT01583595?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2011-12. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01583595?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia